Patents by Inventor Stefano Barabino

Stefano Barabino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPHTHALMIC SOLUTION OF LISSAMINE GREEN AND ITS USE IN OPHTHALMOLOGY
    Publication number: 20200009270
    Abstract: The present invention relates to an ophthalmic solution of lissamine green which has shown to be particularly stable over time and well tolerated by the eye. Therefore, the ophthalmic solution finds advantageous application in the diagnosis of corneal and conjunctival anomalies.
    Type: Application
    Filed: December 14, 2017
    Publication date: January 9, 2020
    Applicant: OFTALAB SRL
    Inventor: Stefano Barabino
  • Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
    Patent number: 8957110
    Abstract: The invention concerns topical compositions for the prevention and treatment of ocular pathologies, in particular inflammatory keratites and conjunctivites and dry eye syndrome, containing as active ingredients polyunsaturated fatty acids of the types omega-3 and omega-6, and specifically EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and GLA (?-linolenic acid), mixed with vitamin E acetate and formulated in a stable composition in hydrogel, i.e. in dispersed form in an aqueous vehicle containing one or more gelling polymers. The proposed compositions are particularly indicated for use as artificial tears.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: February 17, 2015
    Assignee: TRB Chemedica International S.A.
    Inventors: Danilo Aleo, Stefano Barabino, Sergio Mangiafico, Maurizio Rolando, Maria Grazia Antonietta Saita
  • OPHTHALMIC COMPOSITIONS BASED ON POLYUNSATURATED OMEGA-3 AND OMEGA-6 FATTY ACIDS
    Publication number: 20120010280
    Abstract: The invention concerns topical compositions for the prevention and treatment of ocular pathologies, in particular inflammatory keratites and conjunctivites and dry eye syndrome, containing as active ingredients polyunsaturated fatty acids of the types omega-3 and omega-6, and specifically EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and GLA (?-linolenic acid), mixed with vitamin E acetate and formulated in a stable composition in hydrogel, i.e. in dispersed form in an aqueous vehicle containing one or more gelling polymers. The proposed compositions are particularly indicated for use as artificial tears.
    Type: Application
    Filed: March 18, 2010
    Publication date: January 12, 2012
    Applicant: TRB CHEMEDICA INTERNATIONAL S.A.
    Inventors: Danilo Aleo, Stefano Barabino, Sergio Mangiafico, Maurizio Rolando, Maria Grazia Antonietta Saita
  • Dispensing device
    Patent number: D817168
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: May 8, 2018
    Assignee: OFTALAB S.R.L.
    Inventors: Stefano Barabino, Luigi Bisio